Aller au contenu principal
Accès ouvert déclaré 2023 article

Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma

14Citations signalées, ce qui n’est pas une note de qualité
60Institutions déclarées
5Pays d’affiliation déclarés

Rattachement africain : us, ca, br, at, ch. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Importance: Postoperative radiation therapy for close surgical margins in low- to intermediate-grade salivary carcinomas lacks multi-institutional supportive evidence. Objective: To evaluate the oncologic outcomes for low- and intermediate-grade salivary carcinomas with close and positive margins. Design, Setting, and Participants: The American Head and Neck Society Salivary Gland Section conducted a retrospective cohort study from 2010 to 2019 at 41 centers. Margins were classified as R0 (negative), R1 (microscopically positive), or R2 (macroscopically positive). R0 margins were subclassified into clear (>1 mm) or close (≤1 mm). Data analysis was performed from June to October 2023. Main Outcomes and Measures: Main outcomes were risk factors for local recurrence. Results: A total of 865 patients (median [IQR] age at surgery, 56 [43-66] years; 553 female individuals [64%] and 312 male individuals [36%]) were included. Of these, 801 (93%) had parotid carcinoma and 64 (7%) had submandibular gland carcinoma, and 748 (86%) had low-grade tumors and 117 (14%) had intermediate-grade tumors, with the following surgical margins: R0 in 673 (78%), R1 in 168 (19%), and R2 in 24 (3%). Close margins were found in 395 of 499 patients with R0 margins (79%), for whom margin distances were measured. A total of 305 patients (35%) underwent postoperative radiation therapy. Of all 865 patients, 35 (4%) had local recurrence with a median (IQR) follow-up of 35.3 (13.9-59.1) months. In patients with close margins as the sole risk factor for recurrence, the local recurrence rates were similar between those who underwent postoperative radiation therapy (0 of 46) or observation (4 of 165 [2%]). Patients with clear margins (n = 104) had no recurrences. The local recurrence rate in patients with R1 or R2 margins was better in those irradiated (2 of 128 [2%]) compared to observed (13 of 64 [20%]) (hazard ratio [HR], 0.05; 95% CI, 0.01-0.24). Multivariable analysis for local recurrence found the following independent factors: age at diagnosis (HR for a 10-year increase in age, 1.33; 95% CI, 1.06-1.67), R1 vs R0 (HR, 5.21; 95% CI, 2.58-10.54), lymphovascular invasion (HR, 4.47; 95% CI, 1.43-13.99), and postoperative radiation therapy (HR, 0.10; 95% CI, 0.04-0.29). The 3-year local recurrence-free survivals for the study population were 96% vs 97% in the close margin group. Conclusions and Relevance: In this cohort study of patients with low- and intermediate-grade major salivary gland carcinoma, postoperative radiation therapy for positive margins was associated with decreased risk of local recurrence. In isolation from other risk factors for local recurrence, select patients with close surgical margins (≤1 mm) may safely be considered for observation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma
Date Crossref
01/02/2024
Éditeur
American Medical Association (AMA)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

University of Vermont Medical CenterUniversity of VermontHouston MethodistMethodist HospitalUniversity of Arkansas for Medical SciencesSaint Louis UniversityUniversity of Alabama at BirminghamUniversity of California, San FranciscoSunnybrook Health Science CentreUniversity of TorontoToronto East General HospitalHealth Sciences CentreUniversity of Kansas Medical CenterJewish General HospitalLouisiana State University Health Sciences Center ShreveportUMass Memorial Medical CenterDartmouth–Hitchcock Medical CenterNorthwell HealthUniversity of Nebraska at OmahaUniversity of KentuckyWest Virginia UniversityPenn State Milton S. Hershey Medical CenterWinnMedMayo Clinic in FloridaUniversity of California San DiegoThomas Jefferson UniversitySidney Kimmel Cancer CenterTexas Tech UniversityTexas Tech University Health Sciences CenterSalem HospitalUniversidade de São PauloBoston Medical CenterUniversity of Massachusetts Chan Medical SchoolThomas Jefferson University HospitalGeorge Washington UniversityGovernador Celso Ramos HospitalMedical University of ViennaGeorgetown UniversityUniversity of North Carolina at Chapel HillUniversity of ChicagoUniversity of Oklahoma Health Sciences CenterUniversity of OttawaBaptist Hospital of MiamiFlorida International UniversityBaptist Health South FloridaMedical University of South CarolinaUniversity of MinnesotaCleveland ClinicMcGill UniversityEmory UniversityBeneficência Portuguesa de São PauloHospital São PauloUniversidade Federal de São PauloIndiana University – Purdue University IndianapolisSanta Casa de Misericórdia de MaríliaUniversity of California, Los AngelesUniversity of OklahomaKantonsspital St. GallenWestern UniversityTemple University Hospital

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Salivary Gland Tumors Diagnosis and TreatmentHead and Neck Cancer StudiesHead and Neck Surgical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.